These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11119955)

  • 21. Renal transplantation in patients with lupus nephritis: a single-center experience.
    Ghafari A; Etemadi J; Ardalan MR
    Transplant Proc; 2008; 40(1):143-4. PubMed ID: 18261571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BTI-322 for induction therapy after renal transplantation: a randomized study.
    Squifflet JP; Besse T; Malaise J; Mourad M; Delcorde C; Hope JA; Pirson Y
    Transplant Proc; 1997; 29(1-2):317-9. PubMed ID: 9123018
    [No Abstract]   [Full Text] [Related]  

  • 23. Early cyclosporine concentration as predictor of graft survival in cadaveric renal transplantation.
    Salmela K; Kyllönen L
    Transplant Proc; 2001 Jun; 33(4):2441-3. PubMed ID: 11406202
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal transplantation in patients with systemic lupus erythematosus.
    Bitker MO; Barrou B; Ourhama S; Mouquet C; Chartier-Kastler E; Luciani J; Chatelain C
    Transplant Proc; 1993 Jun; 25(3):2172-3. PubMed ID: 8516857
    [No Abstract]   [Full Text] [Related]  

  • 25. Pre- versus intraoperative application of glucocorticosteroids as inductive therapy in renal transplantation.
    Fricke L; Leeker A; Kreft B; Klüter H; Hoyer J; Steinhoff J; Sack K
    Transplant Proc; 1998 Jun; 30(4):1346-7. PubMed ID: 9636547
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
    Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
    Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 28. Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.
    Okazaki H; Sato T; Miura S; Amada N
    Transplant Proc; 1997; 29(1-2):200-2. PubMed ID: 9122962
    [No Abstract]   [Full Text] [Related]  

  • 29. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 30. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

  • 31. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
    Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
    Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term evolution of anti-HCV-positive renal transplant recipients.
    Aroldi A; Lampertico P; Elli A; Lunghi G; Tarantino A; Montagnino G; Colombo M; Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):2076-8. PubMed ID: 9723397
    [No Abstract]   [Full Text] [Related]  

  • 34. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 35. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D; Madras PN; Conway P; Davis C; Simpson MA; Monaco AP
    Transplant Proc; 1997; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract]   [Full Text] [Related]  

  • 37. Transplantation in Singapore.
    Vathsala A; Lee WT; Li MK; Woo KT; Lim CH
    Transplant Proc; 1995 Feb; 27(1):1472-5. PubMed ID: 7878947
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
    Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
    Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract]   [Full Text] [Related]  

  • 40. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
    Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO
    Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.